Blood-based identification of non-responders to anti-TNF therapy in rheumatoid arthritis

BACKGROUND: Faced with an increasing number of choices for biologic therapies, rheumatologists have a critical need for better tools to inform rheumatoid arthritis (RA) disease management. The ability to identify patients who are unlikely to respond to first-line biologic anti-TNF therapies prior to...

Descripción completa

Detalles Bibliográficos
Autores principales: Thomson, Ty M., Lescarbeau, Reynald M., Drubin, David A., Laifenfeld, Daphna, de Graaf, David, Fryburg, David A., Littman, Bruce, Deehan, Renée, Van Hooser, Aaron
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BioMed Central 2015
Materias:
Research Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4455917/
https://www.ncbi.nlm.nih.gov/pubmed/26036272
http://dx.doi.org/10.1186/s12920-015-0100-6

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4455917/
https://www.ncbi.nlm.nih.gov/pubmed/26036272
http://dx.doi.org/10.1186/s12920-015-0100-6

Ejemplares similares